Skip to main content
. Author manuscript; available in PMC: 2017 Dec 13.
Published in final edited form as: Dig Dis Sci. 2016 Mar 8;61(12):3460–3468. doi: 10.1007/s10620-016-4097-2

Fig. 2.

Fig. 2

Primary care physician perspectives on current HCV treatment: comparison of all physicians, up-to-date physicians, and VA physicians. INJ injection. a SVR rate (%), b mode of administration, c treatment duration (weeks), d minimal side effects